|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung KY and Saltz LB: Adjuvant therapy of
colon cancer: current status and future directions. Cancer J.
13:192–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rabik CA and Dolan ME: Molecular
mechanisms of resistance and toxicity associated with platinating
agents. Cancer Treat Rev. 33:9–23. 2007. View Article : Google Scholar :
|
|
4
|
Macdonald JS and Astrow AB: Adjuvant
therapy of colon cancer. Semin Oncol. 28:30–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mann JR, Backlund MG and DuBois RN:
Mechanisms of disease: Inflammatory mediators and cancer
prevention. Nat Clin Pract Oncol. 2:202–210. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li B, Lu F, Wei X and Zhao R: Fucoidan:
structure and bioactivity. Molecules. 13:1671–1695. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamasaki-Miyamoto Y, Yamasaki M, Tachibana
H and Yamada K: Fucoidan induces apoptosis through activation of
caspase-8 on human breast cancer mcf-7 cells. J Agric Food Chem.
57:8677–8682. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bilan MI, Grachev AA, Ustuzhanina NE,
Shashkov AS, Nifantiev NE and Usov AI: Structure of a fucoidan from
the brown seaweed Fucus evanescens C.Ag. Carbohydr Res.
337:719–730. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gideon TP and Rengasamy R: Toxicological
evaluation of fucoidan from Cladosiphon okamuranus. J Med Food.
11:638–642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JB, Hayashi K, Hashimoto M, Nakano T
and Hayashi T: Novel antiviral fucoidan from sporophyll of Undaria
pinnatifida (Mekabu). Chem Pharm Bull (Tokyo). 52:1091–1094. 2004.
View Article : Google Scholar
|
|
11
|
Aisa Y, Miyakawa Y, Nakazato T, et al:
Fucoidan induces apoptosis of human HS-sultan cells accompanied by
activation of caspase-3 and down-regulation of ERK pathways. Am J
Hematol. 78:7–14. 2005. View Article : Google Scholar
|
|
12
|
Koyanagi S, Tanigawa N, Nakagawa H, Soeda
S and Shimeno H: Oversulfation of fucoidan enhances its
anti-angiogenic and antitumor activities. Biochem Pharmacol.
65:173–179. 2003. View Article : Google Scholar
|
|
13
|
Dürig J, Bruhn T, Zurborn KH, Gutensohn K,
Bruhn HD and Béress L: Anticoagulant fucoidan fractions from Fucus
vesiculosus induce platelet activation in vitro. Thromb Res.
85:479–491. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McClure MO, Moore JP, Blanc DF, et al:
Investigations into the mechanism by which sulfated polysaccharides
inhibit HIV infection in vitro. AIDS Res Hum Retroviruses. 8:19–26.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Itoh H, Noda H, Amano H, Zhuaug C, Mizuno
T and Ito H: Antitumor activity and immunological properties of
marine algal polysaccharides, especially fucoidan, prepared from
sargassum thunbergii of phaeophyceae. Anticancer Res. 13:2045–2052.
1993.PubMed/NCBI
|
|
16
|
Zhuang C, Itoh H, Mizuno T and Ito H:
Antitumor active fucoidan from the brown seaweed, umitoranoo
(Sargassum thunbergii). Biosci Biotechnol Biochem. 59:563–567.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alekseyenko TV, Zhanayeva SY, Venediktova
AA, et al: Antitumor and antimetastatic activity of fucoidan, a
sulfated polysaccharide isolated from the Okhotsk Sea Fucus
evanescens brown alga. Bull Exp Biol Med. 143:730–732. 2007.In
English, Russian. View Article : Google Scholar
|
|
18
|
Coombe DR, Parish CR, Ramshaw IA and
Snowden JM: Analysis of the inhibition of tumour metastasis by
sulphated polysaccharides. Int J Cancer. 39:82–88. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Riou D, Colliec-Jouault S, Pinczon du Sel
D, et al: Antitumor and antiproliferative effects of a fucan
extracted from ascophyllum nodosum against a non-small-cell
bronchopulmonary carcinoma line. Anticancer Res. 16:1213–1218.
1996.PubMed/NCBI
|
|
20
|
Ye J, Li Y, Teruya K, et al:
Enzyme-digested fucoidan extracts derived from seaweed mozuku of
cladosiphon novae-caledoniae kylin inhibit invasion and
angiogenesis of tumor cells. Cytotechnology. 47:117–126. 2005.
View Article : Google Scholar
|
|
21
|
Bilan MI, Grachev AA, Ustuzhanina NE,
Shashkov AS, Nifantiev NE and Usov AI: A highly regular fraction of
a fucoidan from the brown seaweed Fucus distichus L. Carbohydr Res.
339:511–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
WCRF/AICR: Policy and Action for cancer
prevention. Food, nutrition and physical activity: A global
perspective. World cancer research fund and American Institute for
Cancer Research; 2009
|
|
23
|
Rajamanickam S and Agarwal R: Natural
products and colon cancer: current status and future prospects.
Drug Dev Res. 69:460–471. 2008. View Article : Google Scholar
|
|
24
|
Hill MM and Hemmings BA: Inhibition of
protein kinase B/Akt. implications for cancer therapy. Pharmacol
Ther. 93:243–251. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye M, Hu D, Tu L, et al: Involvement of
PI3K/Akt signaling pathway in hepatocyte growth factor-induced
migration of uveal melanoma cells. Invest Ophthalmol Vis Sci.
49:497–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Faivre S, Kroemer G and Raymond E: Current
development of mTOR inhibitors as anticancer agents. Nat Rev Drug
Discov. 5:671–688. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Burleson KM, Boente MP, Pambuccian SE and
Skubitz AP: Disaggregation and invasion of ovarian carcinoma
ascites spheroids. J Transl Med. 4:62006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
L'Espérance S, Bachvarova M, Tetu B,
Mes-Masson AM and Bachvarov D: Global gene expression analysis of
early response to chemotherapy treatment in ovarian cancer
spheroids. BMC Genomics. 9:992008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shield K, Riley C, Quinn MA, Rice GE,
Ackland ML and Ahmed N: Alpha2beta1 integrin affects metastatic
potential of ovarian carcinoma spheroids by supporting
disaggregation and proteolysis. J Carcinog. 6:112007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zietarska M, Maugard CM, Filali-Mouhim A,
et al: Molecular description of a 3D in vitro model for the study
of epithelial ovarian cancer (EOC). Mol Carcinog. 46:872–885. 2007.
View Article : Google Scholar : PubMed/NCBI
|
